Skip to content
Case report Open access

Metabolic and neuropathic outcomes following combined sodium-glucose cotransporter-2 inhibitor therapy and adjunctive acupuncture in obese patients with diabetic neuropathy: a case series

Sep 2026 · Frontiers in Pain Research · Vol 7 · 0 citations · 48 references
Medicine

TL;DR

Combined therapy with SGLT2 inhibitors and acupuncture was associated with improvements in metabolic, neuropathic, and functional outcomes in obese patients with T2DM, and DPN, suggesting that a potential multidimensional therapeutic approach, however, larger controlled studies are required to confirm efficacy.

Abstract

Background Obesity and type 2 diabetes mellitus (T2DM) are associated with chronic metabolic dysregulation and microvascular complications, including diabetic peripheral neuropathy (DPN). This case series describes metabolic and patient reported outcomes during ongoing empagliflozin therapy with adjunctive acupuncture treatment. Methods The prospective observational case series included three adult participants with obesity, T2DM, and symptom defined DPN. All participants received empagliflozin 10 mg daily for at least 4 weeks before enrollment and continued treatment while receiving standardized acupuncture twice weekly for 10 weeks. Primary outcomes included body weight, body mass index (BMI), and waist circumference. Secondary outcomes included neuropathic pain intensity assessed using the visual analogue scale (VAS), sleep quality measured by a single-item sleep quality score, and fatigue assessed using the fatigue severity scale were recorded at baseline and week 10. Results All participants completed the intervention without adverse events. The body weight decreased by 4–9 kg, BMI by 1.2–3.5 kg/m2, and waist circumference by 5–10 cm. VAS reduction range from 2 to 4 points, sleep quality and fatigue scores also improved consistently in all cases. Exploratory outcomes indicated enhanced mobility, reduced nocturnal neuropathic symptoms, and high treatment tolerability. Conclusion Combined therapy with SGLT2 inhibitors and acupuncture was associated with improvements in metabolic, neuropathic, and functional outcomes in obese patients with T2DM, and DPN. These findings suggest that a potential multidimensional therapeutic approach, however, larger controlled studies are required to confirm efficacy.

Read PDF

Similar papers

Open access Oct 2026

Laser + Needle Acupuncture Synergy Technique: Breakthrough Outcomes in Chronic Type 2 Diabetes and Wound Healing

Type 2 diabetes mellitus (T2DM) is frequently complicated by neuropathy, impaired wound healing, and poor glycemic control, creating significant clinical and economic burdens. Adjunctive modalities such as acupuncture and photobiomodulation have gained interest for their potential to support glycemic control and improv...

Choon Huat Lim · 0 citations
Review Open access Nov 2026

Metabolic and biochemical predictors of glycemic response after bariatric surgery: a scoping review.

Glycemic improvement after bariatric surgery is associated with complex metabolic interactions involving insulin sensitivity, incretin modulation, and inflammatory changes, which support the role of bariatric and metabolic surgery as a metabolic and immunometabolic intervention.

Matheus P. S. Netto, I. Duval-Araujo, A. Tinoco · 0 citations
Open access Oct 2026

Effects of Empagliflozin on Oxidative Stress in Patients with Obstructive Sleep Apnea and Heart Failure: A Randomized Clinical Trial

Obstructive sleep apnea (OSA) and heart failure (HF) share pathways involving intermittent hypoxia and oxidative stress. This randomized clinical trial with blinded endpoint assessment evaluated systemic oxidative balance during sequential treatment with empagliflozin and continuous positive airway pressure (CPAP). Sev...

Agnieszka Polecka, U. Cwalina, E. Olszewska · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.